Search Results

There are 2118 results for: content related to: Lead inhibits paraoxonase 2 but not paraoxonase 1 activity in human hepatoma HepG2 cells

  1. Effects of PON polymorphisms and haplotypes on molecular phenotype in Mexican-American mothers and children

    Environmental and Molecular Mutagenesis

    Volume 52, Issue 2, March 2011, Pages: 105–116, Karen Huen, Lisa Barcellos, Kenneth Beckman, Sherri Rose, Brenda Eskenazi and Nina Holland

    Version of Record online : 26 MAR 2010, DOI: 10.1002/em.20567

  2. CHO cell expression, long-term stability, and primate pharmacokinetics and brain uptake of an IgG–paroxonase-1 fusion protein

    Biotechnology and Bioengineering

    Volume 108, Issue 1, January 2011, Pages: 186–196, Ruben J. Boado, Eric Ka-Wai Hui, Jeff Zhiqiang Lu and William M. Pardridge

    Version of Record online : 11 OCT 2010, DOI: 10.1002/bit.22907

  3. You have free access to this content
    Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme

    Protein Science

    Volume 22, Issue 12, December 2013, Pages: 1799–1807, Priyanka Bajaj, Rajan K. Tripathy, Geetika Aggarwal and Abhay H. Pande

    Version of Record online : 26 OCT 2013, DOI: 10.1002/pro.2380

  4. You have free access to this content
    Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 54, Issue 6, June 2006, Pages: 1928–1939, Laura M. Tripi, Susan Manzi, Qi Chen, Margaret Kenney, Penny Shaw, Amy Kao, Franklin Bontempo, Candace Kammerer and M. Ilyas Kamboh

    Version of Record online : 25 MAY 2006, DOI: 10.1002/art.21889

  5. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies


    Volume 38, Issue 4, July/August 2012, Pages: 292–299, Mira Rosenblat, Sarah Ward, Nina Volkova, Tony Hayek and Michael Aviram

    Version of Record online : 4 JUN 2012, DOI: 10.1002/biof.1021

  6. Paraoxonase 1-treated oxLDL promotes cholesterol efflux from macrophages by stimulating the PPARγ–LXRα–ABCA1 pathway

    FEBS Letters

    Volume 590, Issue 11, June 2016, Pages: 1614–1629, Souade Ikhlef, Hicham Berrougui, Olivier Kamtchueng Simo and Abdelouahed Khalil

    Version of Record online : 23 MAY 2016, DOI: 10.1002/1873-3468.12198

  7. You have free access to this content
    Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase

    The FEBS Journal

    Volume 273, Issue 9, May 2006, Pages: 1906–1919, Gabriel Amitai, Leonid Gaidukov, Rellie Adani, Shelly Yishay, Guy Yacov, Moshe Kushnir, Shai Teitlboim, Michal Lindenbaum, Peter Bel, Olga Khersonsky, Dan S. Tawfik and Haim Meshulam

    Version of Record online : 5 APR 2006, DOI: 10.1111/j.1742-4658.2006.05198.x

  8. You have free access to this content
    Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities

    Journal of Neurochemistry

    Volume 92, Issue 5, March 2005, Pages: 1216–1227, Boris Bryk, Liat BenMoyal-Segal, Erez Podoly, Oded Livnah, Arik Eisenkraft, Shai Luria, Amir Cohen, Yoav Yehezkelli, Ariel Hourvitz and Hermona Soreq

    Version of Record online : 4 FEB 2005, DOI: 10.1111/j.1471-4159.2004.02959.x

  9. Serum paraoxonase 1 activity in dogs: preanalytical and analytical factors and correlation with C-reactive protein and alpha-2-globulin

    Veterinary Clinical Pathology

    Volume 42, Issue 3, September 2013, Pages: 329–341, Gabriele Rossi, Alessia Giordano, Francesca Pezzia, Mads Kjelgaard-Hansen and Saverio Paltrinieri

    Version of Record online : 14 AUG 2013, DOI: 10.1111/vcp.12073

  10. Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study)

    Diabetic Medicine

    Volume 25, Issue 2, February 2008, Pages: 186–193, S. W. Van Den Berg, E. H. J. Jansen, M. Kruijshoop, P. K. Beekhof, E. Blaak, C. J. Van Der Kallen, M. M. Van Greevenbroek and E. J. M. Feskens

    Version of Record online : 15 FEB 2008, DOI: 10.1111/j.1464-5491.2007.02328.x

  11. Preparation of paraoxonase-1 liposomes and studies on their in vivo pharmacokinetics in rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 41, Issue 10, October 2014, Pages: 825–829, Zhen-Kun Han, Zhen-Ning Liu, Li Yuan, Peng-Si Zhang and Min Zhao

    Version of Record online : 30 OCT 2014, DOI: 10.1111/1440-1681.12275

  12. You have free access to this content
    Gender Related Differences in Paraoxonase 1 Response to High-fat Diet-induced Oxidative Stress


    Volume 16, Issue 10, October 2008, Pages: 2232–2238, Elena Thomàs-Moyà, Yolanda Gómez-Pérez, Miguel Fiol, Magdalena Gianotti, Isabel Lladó and Ana M. Proenza

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2008.340

  13. Immunobiochemical analysis of paraoxonase1 (anti-oxidant), xanthine oxidase (oxidant) enzymes and lipid profile of cardiac disease patients in Lahore Metropolitan, Pakistan

    Journal of Clinical Laboratory Analysis

    Volume 24, Issue 5, 2010, Pages: 348–356, Zahoor Qadir Samra, Adeela Sana, Sadia Bano, Mariam Farooq, Nadia Dar and Muhammad Amin Athar

    Version of Record online : 20 SEP 2010, DOI: 10.1002/jcla.20417

  14. You have full text access to this OnlineOpen article
    Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides

    Diabetic Medicine

    Volume 25, Issue 9, September 2008, Pages: 1049–1055, M. Mastorikou, B. Mackness, Y. Liu and M. Mackness

    Version of Record online : 29 AUG 2008, DOI: 10.1111/j.1464-5491.2008.02546.x

  15. You have full text access to this Open Access content
    Genistein as a potential inducer of the anti-atherogenic enzyme paraoxonase-1: studies in cultured hepatocytes in vitro and in rat liver in vivo

    Journal of Cellular and Molecular Medicine

    Volume 16, Issue 10, October 2012, Pages: 2331–2341, Charlotte Schrader, Insa M. A. Ernst, Heike Sinnecker, Sebastian T. Soukup, Sabine E. Kulling and Gerald Rimbach

    Version of Record online : 26 SEP 2012, DOI: 10.1111/j.1582-4934.2012.01542.x

    Corrected by:

    Erratum: Erratum

    Vol. 18, Issue 8, 1704, Version of Record online: 2 SEP 2014

  16. You have free access to this content
    The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia

    Journal of Internal Medicine

    Volume 258, Issue 5, November 2005, Pages: 442–449, T. M. VAN HIMBERGEN, L. J. H. VAN TITS, H. A. M. VOORBIJ, J. DE GRAAF, A. F. H. STALENHOEF and M. ROEST

    Version of Record online : 22 SEP 2005, DOI: 10.1111/j.1365-2796.2005.01557.x

  17. Downregulation of human paraoxonase 1 (PON1) by organophosphate pesticides in HepG2 cells

    Environmental Toxicology

    Irma Martha Medina-Díaz, Néstor Ponce-Ruiz, Bryana Ramírez-Chávez, Aurora Elizabeth Rojas-García, Briscia S. Barrón-Vivanco, Guillermo Elizondo and Yael Y. Bernal-Hernández

    Version of Record online : 7 MAR 2016, DOI: 10.1002/tox.22253

  18. You have free access to this content
    Genetic Variation in the Paraoxonase-3 (PON3) Gene is Associated with Serum PON1 Activity

    Annals of Human Genetics

    Volume 72, Issue 1, January 2008, Pages: 72–81, Dharambir K. Sanghera, Susan Manzi, Ryan L. Minster, Penny Shaw, Amy Kao, Franklin Bontempo and M. Ilyas Kamboh

    Version of Record online : 27 SEP 2007, DOI: 10.1111/j.1469-1809.2007.00400.x

  19. PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenaemia

    Clinical Endocrinology

    Volume 79, Issue 2, August 2013, Pages: 259–266, George Paltoglou, George Tavernarakis, Panagiotis Christopoulos, Margarita Vlassi, Maria Gazouli, Efthimios Deligeoroglou, George Creatsas and George Mastorakos

    Version of Record online : 11 MAY 2013, DOI: 10.1111/cen.12139

  20. Paraoxonase activity in two healthy populations with differing rates of coronary heart disease

    European Journal of Clinical Investigation

    Volume 30, Issue 1, January 2000, Pages: 4–10, Mackness, Mackness, Durrington, Arrol, Evans, McMaster, Ferrières, Ruidavets, Williams and Howard

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2362.2000.00580.x